Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bristol-Myers Squibb
Bristol-Myers Squibb
Revisiting My Bullish Thesis On Bristol-Myers Squib
Seeking Alpha
Sun, 01/12/14 - 09:19 am
Bristol-Myers Squibb
M&A Boom Seen in 2014 as Drug Hunt Spurs Biotech Deals
Bloomberg
Fri, 01/10/14 - 08:25 am
M&A
biotech
generics
Merck
Bristol-Myers Squibb
General Electric
Gilead Sciences
Thermo Fisher
Forest Labs
FDA
Acorda Therapeutics
Pfizer
JNJ
Roche
Pharmacyclics
Bristol-AstraZeneca Diabetes Drug Wins U.S. FDA Approval
Bloomberg
Wed, 01/8/14 - 04:20 pm
Dapagliflozin
FDA
Bristol-Myers Squibb
diabetes
AstraZeneca
Bristol-Myers Squibb Vs. Roche In The Brain Cancer Race
Seeking Alpha
Thu, 01/2/14 - 09:35 am
Bristol-Myers Squibb
Roche
brain cancer
CytRx
Celldex Therapeutics
ImmunoCellular Therapeutics
Northwest Biotherapeutics
glioblastoma multiforme
nivolumab
Yervoy
Grading Pharma In 2013: 16 Drug Companies Ranked
Forbes
Tue, 12/31/13 - 10:17 am
Bristol-Myers Squibb
Celgene
Gilead Sciences
Biogen Idec
AbbVie
Roche
JNJ
GSK
Amgen
Novo Nordisk
Pfizer
Novartis
Merck
Sanofi
AstraZeneca
Eli Lilly
Big Pharma Stocks: Year in Review
Yahoo/TheStreet.com
Tue, 12/24/13 - 09:50 am
Big Pharma
drug stocks
Merck
JNJ
GSK
Eli Lilly
Pfizer
Sanofi
Bristol-Myers Squibb
Bristol-Myers sale of diabetes franchise positive, says BMO Capital
The Fly on the Wall
Mon, 12/23/13 - 11:12 am
diabetes
M&A
Bristol-Myers Squibb
AstraZeneca
Inovio CEO Interview: PD1/PDL1 Inhibitors, Immunotherapy And Why Investors Should Be Excited About 2014
Seeking Alpha
Fri, 12/20/13 - 11:49 am
Inovio
Pharma CEOs
PDL-1
immunotherapy
Joseph Kim
Bristol-Myers Squibb
Roche
Dendreon
GSK
ImmunoCellular Therapeutics
Merck
Northwest Biotherapeutics
AstraZeneca to buy Bristol out of diabetes venture for up to $4.1 billion
Yahoo/Reuters
Thu, 12/19/13 - 08:12 am
Bristol-Myers Squibb
diabetes
AstraZeneca
3 Reasons Why Bristol-Myers Squibb Could Make an Awesome Comeback
Motley Fool
Wed, 12/18/13 - 08:22 am
Bristol-Myers Squibb
The Best Biotech CEO of 2013 is...
TheStreet.com
Tue, 12/17/13 - 08:49 am
biotech
Celgene
NPS Pharmaceuticals
Bristol-Myers Squibb
ONYX Pharmaceuticals
Bristol, AstraZeneca withdraw diabetes drug in Germany, the day after it was endorsed by an FDA panel
Yahoo/Reuters
Fri, 12/13/13 - 10:43 am
Germany
diabetes
AstraZeneca
Dapagliflozin
Bristol-Myers Squibb
FDA panel backs Bristol diabetes drug after prior rejection
Yahoo/Reuters
Thu, 12/12/13 - 05:01 pm
FDA
advisory panels
Bristol-Myers Squibb
diabetes
Dapagliflozin
FDA panel throws dirt on Bristol-Myers' orphan drug metreleptin
Fierce Biotech
Thu, 12/12/13 - 04:15 pm
FDA
advisory panels
Bristol-Myers Squibb
metreleptin
AstraZeneca
partial lipodystrophy
Keep an Eye on AstraZeneca, Avanir, Bristol-Myers Squibb and VIVUS Today
Motley Fool
Thu, 12/12/13 - 11:12 am
AstraZeneca
Avair
Bristol-Myers Squibb
Vivus
metreleptin
Nuedexta
Avanafil
Sanofi
3 Important Catalysts That Fueled Repligen in 2013
Motley Fool
Thu, 12/12/13 - 08:42 am
Repligen
Orencia
Bristol-Myers Squibb
monoclonal antibodies
Bristol adds medicine to patent pool for AIDS drugs
Yahoo/Reuters
Thu, 12/12/13 - 06:50 am
AIDS
HIV
Bristol-Myers Squibb
patents
Reyataz
Bristol drug for fat disorder may work, but risky - FDA staff
Reuters
Tue, 12/10/13 - 09:46 am
Bristol-Myers Squibb
FDA
metreleptin
FDA staff cautious on AstraZeneca, Bristol diabetes drug
Yahoo/Reuters
Tue, 12/10/13 - 09:21 am
FDA
AstraZeneca
Bristol-Myers Squibb
Dapagliflozin
diabetes
3 Budding Drug Superstars in This Big Pharma's Future
Motley Fool
Sat, 12/7/13 - 01:12 pm
Bristol-Myers Squibb
Pages
« first
‹ previous
…
51
52
53
54
55
56
57
58
59
…
next ›
last »